Cord Tissue Stem Cells Heal Crohn’s Disease Fistulas

Cord Tissue Stem Cells Heal Crohn’s Disease Fistulas

A new meta-analysis is highlighting the potential of umbilical cord-derived mesenchymal stem cells (MSCs) as a treatment for Crohn’s-related fistulas.

In New Zealand, more than 20,000 people are affected by inflammatory bowel disease, one of the highest rates in the world.

The analysis pooled data from 25 studies across Europe, North America and Asia, involving 596 patients. The results surpassed traditional methods, showing remission rates of 57.9% at six months and 52% at one year.

Crohn’s disease often leads to fistulas — painful and complex complications that are difficult to treat. Many patients live with chronic pain, infection and repeated operations. Traditional therapies such as antibiotics, immunosuppressants, biologics and surgery have limited success, with healing rates around 30% and frequent complications.

Read more here.